Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
A 2026 review examines approved and unapproved peptides for musculoskeletal injuries and athletic performance. Learn what the evidence actually shows.
By Peptide Association Research Team
Comprehensive study examines approved and unapproved peptides for musculoskeletal injuries. Learn about safety profiles and regulatory status.
By Peptide Association Research Team
New research examines approved vs unapproved peptides for musculoskeletal injuries. Study reveals safety gaps in gray market compounds lacking oversight.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team